Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Institute of Nephrology, Peking University, Beijing, China.
Ren Fail. 2024 Dec;46(1):2310122. doi: 10.1080/0886022X.2024.2310122. Epub 2024 Feb 12.
Hypertensive nephropathy continues to be a major cause of end-stage renal disease and poses a significant global health burden. Despite the staggering development of research in hypertensive nephropathy, scientists and clinicians can only seek out useful information through articles and reviews, it remains a hurdle for them to quickly track the trend in this field. This study uses the bibliometric method to identify the evolutionary development and recent hotspots of hypertensive nephropathy. The Web of Science Core Collection database was used to extract publications on hypertensive nephropathy from January 2000 to November 2023. CiteSpace was used to capture the patterns and trends from multi-perspectives, including countries/regions, institutions, keywords, and references. In total, 557 publications on hypertensive nephropathy were eligible for inclusion. China (= 208, 37.34%) was the most influential contributor among all the countries. Veterans Health Administration (= 19, 3.41%) was found to be the most productive institution. Keyword bursting till now are renal fibrosis, outcomes, and mechanisms which are predicted to be the potential frontiers and hotspots in the future. The top seven references were listed, and their burst strength was shown. A comprehensive overview of the current status and research frontiers of hypertensive nephropathy has been provided through the bibliometric perspective. Recent advancements and challenges in hypertensive nephropathy have been discussed. These findings can offer informative instructions for researchers and scholars.
高血压肾病仍然是终末期肾病的主要原因,并对全球健康造成重大负担。尽管在高血压肾病的研究方面取得了惊人的进展,但科学家和临床医生只能通过文章和综述来寻找有用的信息,因此他们很难快速跟踪该领域的趋势。本研究使用文献计量学方法来确定高血压肾病的演变发展和近期热点。从 2000 年 1 月到 2023 年 11 月,从 Web of Science 核心合集数据库中提取了关于高血压肾病的出版物。CiteSpace 用于从多个角度捕捉模式和趋势,包括国家/地区、机构、关键词和参考文献。共有 557 篇关于高血压肾病的出版物符合纳入标准。在所有国家中,中国(=208,37.34%)的影响力最大。退伍军人健康管理局(=19,3.41%)是最有成效的机构。目前的关键词突发是肾纤维化、结局和机制,预计这些将是未来的潜在前沿和热点。列出了前七篇参考文献,并展示了它们的突发强度。通过文献计量学的视角,对高血压肾病的现状和研究前沿进行了全面概述。讨论了高血压肾病的最新进展和挑战。这些发现可为研究人员和学者提供有价值的指导。
Int Urol Nephrol. 2024-2
Front Public Health. 2022
Complement Ther Med. 2023-12
Medicine (Baltimore). 2024-1-19
Front Biosci (Landmark Ed). 2022-8-31
Front Oral Health. 2025-7-14
Front Microbiol. 2025-3-4
Quant Imaging Med Surg. 2024-7-1
Int Urol Nephrol. 2024-2
Signal Transduct Target Ther. 2023-3-13
Int J Mol Sci. 2022-12-14
Oxid Med Cell Longev. 2022
Nat Rev Nephrol. 2022-11